Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin - Rousseau, A; Van Dreden, P; Mbemba, E; Elalamy, I; Larsen, A; Gerotziafas, G T (Thromb Res, 2015)